Melbourne, Nov 7, 2008 (ABN Newswire) - Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB)(PINK:MBLTY), is featured today at the 2008 UBS Australian Healthcare Conference underway in Sydney as one of three leading emerging companies in the biotechnology space.
